Literature DB >> 14304246

LABORATORY STUDIES ON PATIENTS RECEIVING ANTICOAGULANT THERAPY.

S SHAW, G D PEGRUM, S WOLFF.   

Abstract

An investigation into the laboratory control of anticoagulant therapy is presented. The cases were divided into those in the first few weeks of therapy and those on long-term treatment. Variations in the levels of factors VII and X, and factor IX were assessed. Thromboplastin levels were used to control therapy. These were compared with parallel estimations by Thrombotest and with the levels of the coagulation factors. Thrombotest was found to have no major advantage over thromboplastin.

Entities:  

Keywords:  ANTICOAGULANTS; BLOOD COAGULATION TESTS; DRUG THERAPY; FACTOR IX; FACTOR VII; FACTOR X; PROTHROMBIN TIME

Mesh:

Substances:

Year:  1965        PMID: 14304246      PMCID: PMC472934          DOI: 10.1136/jcp.18.3.327

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

1.  PROTHROMBIN-TIME AND THROMBOTEST IN INJURED PATIENTS ON PROPHYLACTIC ANTICOAGULANT THERAPY.

Authors:  S SEVITT; D INNES
Journal:  Lancet       Date:  1964-01-18       Impact factor: 79.321

2.  The specific assay of Prower-Stuart factor and factor VII.

Authors:  K W DENSON
Journal:  Acta Haematol       Date:  1961-02       Impact factor: 2.195

3.  The Stuart-Prower factor assay and its clinical significance.

Authors:  F BACHMANN; F DUCKERT; F KOLLER
Journal:  Thromb Diath Haemorrh       Date:  1958-05-01

4.  Thrombotest. A new method for controlling anticoagulant therapy.

Authors:  P A OWREN
Journal:  Lancet       Date:  1959-11-07       Impact factor: 79.321

5.  Relation of hemorrhage and thrombosis to prothrombin during treatment with coumarin-type anticoagulants.

Authors:  H S SISE; S M LAVELLE; D ADAMIS; R BECKER
Journal:  N Engl J Med       Date:  1958-08-07       Impact factor: 91.245

6.  The thromboplastin generation test.

Authors:  R BIGGS; A S DOUGLAS
Journal:  J Clin Pathol       Date:  1953-02       Impact factor: 3.411

7.  Relation between levels of plasma thromboplastin component (PTC) and prothrombin times by the P&P and Quick methods in patients receiving warfarin.

Authors:  S I RAPAPORT; S B AMES
Journal:  N Engl J Med       Date:  1962-07-19       Impact factor: 91.245

8.  Comparison of the thrombotest with the one-stage prothrombin time.

Authors:  A J QUICK; C V HUSSEY
Journal:  N Engl J Med       Date:  1961-12-28       Impact factor: 91.245

9.  The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin.

Authors:  P A OWREN; K AAS
Journal:  Scand J Clin Lab Invest       Date:  1951       Impact factor: 1.713

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.